Company / SG&A per Share
INOVIO PHARMACEUTICALS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.02
FY2025
5-year range
$0.15 / $2.55
FY2021-FY2025
Trend
-50.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2021 to $2.55 in FY2023.
Based on SEC 10-K filings.
1.02 in FY2025 with a 5-year CAGR of +28.8%.
Improved from $2.55 to $1.02 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +81.5%
- 5-Year CAGR
- +28.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 50.9% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | -50.9% |
| FY2024 | $2.09 | -18.1% |
| FY2023 | $2.55 | +1387.4% |
| FY2022 | $0.17 | +17.7% |
| FY2021 | $0.15 | -49.7% |
| FY2020 | $0.29 | -0.6% |
| FY2019 | $0.29 | +10.0% |
| FY2018 | $0.26 | +8.4% |
| FY2017 | $0.24 | +11.1% |
| FY2016 | $0.22 | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026